Deletion of Specific Immune-Modulatory Genes from Modified Vaccinia Virus Ankara-Based HIV Vaccines Engenders Improved Immunogenicity in Rhesus Macaques

Modified vaccinia virus Ankara (MVA) is a safe, attenuated orthopoxvirus that is being developed as a vaccine vector but has demonstrated limited immunogenicity in several early-phase clinical trials. Our objective was to rationally improve the immunogenicity of MVA-based HIV/AIDS vaccines via the t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Garber, David A., O'Mara, Leigh A., Gangadhara, Sailaja, McQuoid, Monica, Zhang, Xiugen, Zheng, Rui, Gill, Kiran, Verma, Meena, Yu, Tianwei, Johnson, Brent, Li, Bing, Derdeyn, Cynthia A., Ibegbu, Chris, Altman, John D., Hunter, Eric, Feinberg, Mark B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3497691/
https://ncbi.nlm.nih.gov/pubmed/22973033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00246-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados